Régis Bataille

23.5k total citations · 1 hit paper
269 papers, 16.9k citations indexed

About

Régis Bataille is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Régis Bataille has authored 269 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Hematology, 115 papers in Molecular Biology and 104 papers in Oncology. Recurrent topics in Régis Bataille's work include Multiple Myeloma Research and Treatments (193 papers), Chronic Lymphocytic Leukemia Research (38 papers) and Glycosylation and Glycoproteins Research (36 papers). Régis Bataille is often cited by papers focused on Multiple Myeloma Research and Treatments (193 papers), Chronic Lymphocytic Leukemia Research (38 papers) and Glycosylation and Glycoproteins Research (36 papers). Régis Bataille collaborates with scholars based in France, Canada and United States. Régis Bataille's co-authors include Bernard Klein, Jean‐Luc Harousseau, Martine Amiot, Hervé Avet‐Loiseau, Catherine Pellat‐Deceunynck, Philippe Moreau, Nelly Robillard, M Jourdan, Sophie Barillé‐Nion and J Sany and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Régis Bataille

265 papers receiving 16.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

1989 650 citations Bernard Klein, M Jourdan et al. profile →

Peers

Countries citing papers authored by Régis Bataille

Since Specialization

Citations

This map shows the geographic impact of Régis Bataille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Régis Bataille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Régis Bataille more than expected).

Fields of papers citing papers by Régis Bataille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Régis Bataille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Régis Bataille. The network helps show where Régis Bataille may publish in the future.

Co-authorship network of co-authors of Régis Bataille

This figure shows the co-authorship network connecting the top 25 collaborators of Régis Bataille. A scholar is included among the top collaborators of Régis Bataille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Régis Bataille. Régis Bataille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis 2023 ·Biology ·Jean‐Pascal Capp, Régis Bataille	3
2	Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells 2012 ·Cancer Research ·Sylvanie Surget, David Chiron, Patricia Gomez‐Bougie, Géraldine Descamps, Emmanuelle Ménoret, Régis Bataille, Philippe Moreau, Steven Le Gouill, Martine Amiot, Catherine Pellat‐Deceunynck	58
3	A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines 2010 ·Haematologica ·Jérôme Moreaux, Bernard Klein, Régis Bataille, Géraldine Descamps, Sophie Maïga, Dirk Hose, (unknown), Anna Jauch, Thierry Rème, M Jourdan, Martine Amiot, Catherine Pellat‐Deceunynck	124
4	Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings 2010 ·Advances in Therapy ·Cédric Annweiler, (unknown), Bruno Fantino, Érick Legrand, Régis Bataille, Manuel Montero‐Odasso, Olivier Beauchet	19
5	Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome 2008 ·Journal of Clinical Oncology ·Olivier Decaux, Laurence Lodé, Florence Magrangeas, Catherine Guérin‐Charbonnel, Wilfried Gouraud, Pascal Jézéquel, Michel Attal, Jean‐Luc Harousseau, Philippe Moreau, Régis Bataille, L. Campion, Hervé Avet‐Loiseau, Stéphane Minvielle	269
6	IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop 2008 ·The Journal of Immunology ·Emmanuelle Ménoret, Sophie Maïga, Géraldine Descamps, Catherine Pellat‐Deceunynck, Caroline Fraslon, (unknown), Philippe Moreau, Régis Bataille, Martine Amiot	30
7	CD45neg but Not CD45pos Human Myeloma Cells Are Sensitive to the Inhibition of IGF-1 Signaling by a Murine Anti-IGF-1R Monoclonal Antibody, mAVE1642 2006 ·The Journal of Immunology ·Géraldine Descamps, Soraya Wuillème‐Toumi, Valérie Trichet, Corinne Venot, Laurent Debüssche, Thierry Hercend, M. Collette, Nelly Robillard, Régis Bataille, Martine Amiot	32
8	The Magnitude of Akt/Phosphatidylinositol 3′-Kinase Proliferating Signaling Is Related to CD45 Expression in Human Myeloma Cells 2004 ·The Journal of Immunology ·Géraldine Descamps, Catherine Pellat‐Deceunynck, (unknown), Régis Bataille, Nelly Robillard, Martine Amiot	34
9	The imbalance between Bim and Mcl‐1 expression controls the survival of human myeloma cells 2004 ·European Journal of Immunology ·Patricia Gomez‐Bougie, Régis Bataille, Martine Amiot	78
10	A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy 2003 ·Immunological Reviews ·Régis Bataille, Nelly Robillard, Catherine Pellat‐Deceunynck, Martine Amiot	42
11	IgG‐secreting lymphoplasmacytoid leukaemia: a B‐cell disorder with extensively mutated V_H genes undergoing Ig isotype‐switching frequently associated with trisomy 12 2000 ·British Journal of Haematology ·Richard Garand, Surinder S. Sahota, Hervé Avet‐Loiseau, Pascaline Talmant, Nelly Robillard, Philippe Moreau, Fanny Gaillard, Freda K. Stevenson, Régis Bataille	11
12	Detection of Translocation t(11;14)(q13;q32) in Mantle Cell Lymphoma by Fluorescence in Situ Hybridization 1999 ·American Journal Of Pathology ·Jianyong Li, Fanny Gaillard, Philippe Moreau, Jean‐Luc Harousseau, Christian Laboisse, Nöel Milpied, Régis Bataille, Hervé Avet‐Loiseau	141
13	Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma 1999 ·Bone Marrow Transplantation ·Philippe Moreau, Nöel Milpied, Beatrice Mahé, Nadine Juge‐Morineau, Rapp Mj, Régis Bataille, (unknown)	76
14	The Retinoblastoma Susceptibility Gene RB-1 in Multiple Myeloma 1997 ·Leukemia & lymphoma ·Nadine Juge‐Morineau, J L Harousseau, Martine Amiot, Régis Bataille	20
15	Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products 1997 ·PubMed ·Sylvie Hermouet, (unknown), (unknown), Danielle Pineau, Nelly Robillard, Régis Bataille, Nöel Milpied, J L Harousseau, Beatrice Mahé	12
16	A pilot study of 220 mg/m² melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity 1996 ·British Journal of Haematology ·Philippe Moreau, Marie-France Kerguéris, Nöel Milpied, (unknown), Beatrice Mahé, Claude‐Eric Bulabois, (unknown), C Larousse, Régis Bataille, Jean‐Luc Harousseau	27
17	Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. 1994 ·The Journal of Experimental Medicine ·(unknown), (unknown), Zhao‐Yang Lu, Kiyoshi Yasukawa, George D. Yancopoulos, Katherine J. Turner, M. Shoyab, Tetsuya Taga, Tadamitsu Kishimoto, Régis Bataille	193
18	Interleukin-6 is a Major Myeloma Cell Growth Factor In Vitro and In Vivo Especially in Patients with Terminal Disease 1990 ·Current topics in microbiology and immunology ·Bernard Klein, (unknown), M Jourdan, M Portier, Régis Bataille	29
19	No detectable malignant B cells in the peripheral blood of patients with multiple myeloma 1989 ·British Journal of Haematology ·(unknown), Bernard Klein, Thérèse Commes, N. Ghanem, Marie‐Paule Lefranc, Régis Bataille	33
20	[IgM kappa Waldenström's disease with cryoglobulinemia disclosed by visceral leishmaniasis]. 1988 ·PubMed ·(unknown), Régis Bataille, (unknown), (unknown), J Sany	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact